US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Guillemot Corp (0NB2) 銘柄情報

Guillemot Corp (0NB2)

5.50

0.00

(0.00%)

終了 7月11日 12:30AM

Guillemot Corp (0NB2) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

5.50

( - )

買値

5.50

売値

5.50

出来高

0.00

平均取引量 (3 か月)

10,852 €

財務取引量

-

0.00 日の範囲 0.00

5.50 52 週間の範囲 5.50

時価総額

企業価値

39.207M

前日終値

5.50

始値

-

時刻

最終取引時間

VWAP

-

歳入

127.22M

純利益

-2.43M

発行済株式数

14,621,480

浮動株比率 (%)

27.91%

機関投資家保有比率 (%)

1.17%

配当利回り

0.13 (2.78%)

PER

-25.44

株価売上高倍率 (PSR)

0.49

1 株当たり利益 (EPS)

-0.17

ベータ

0.06

Guillemot Corporation S.A. engages in designing, manufacturing, and selling of interactive entertainment equipment and accessories in European Union, the United Kingdom, North America, and internationally. The company offers DJ controllers, speakers, headphones, and software and stream audio control... Guillemot Corporation S.A. engages in designing, manufacturing, and selling of interactive entertainment equipment and accessories in European Union, the United Kingdom, North America, and internationally. The company offers DJ controllers, speakers, headphones, and software and stream audio controllers; gaming accessories for PCs and consoles, including racing wheels, gamepads, joysticks, and gaming headsets; and software products. It sells its products under the Hercules, DJUCED, and Thrustmaster brand names. The company was founded in 1984 and is based in Carentoir, France. 詳細を表示

セクター

Information Technology

業界

Technology Hardware, Storage & Peripherals

ウェブサイト

www.guillemot.com

本社

Carentoir, France

設立

1984

Guillemot Corp is listed in the Information Technology sector of the ロンドン証券取引所 with ticker 0NB2. The last closing price for Guillemot was 5.50 €. Over the last year, Guillemot shares have traded in a share price range of 5.50 € to 5.50 €.

Guillemot currently has 14,621,480 shares in issue. The market capitalisation of Guillemot is 80.42 € million. Guillemot has a price to earnings ratio (PE ratio) of -25.44.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	5.5	5.5	5.5	38	5.5	DE
52	0	0	5.5	5.5	5.5	100	5.5	DE
156	0	0	5.5	5.5	5.5	97	5.5	DE
260	0	0	5.5	5.5	5.5	634	5.5	DE

0NB2 - Frequently Asked Questions (FAQ)

What is the current Guillemot Corp share price?

The current share price of Guillemot Corp is 5.50 €

How many Guillemot Corp shares are in issue?

Guillemot Corp has 14,621,480 shares in issue

What is the market cap of Guillemot Corp?

The market capitalisation of Guillemot Corp is EUR 80.42M

What is the 1 year trading range for Guillemot Corp share price?

Guillemot Corp has traded in the range of 5.50 € to 5.50 € during the past year

What is the PE ratio of Guillemot Corp?

The price to earnings ratio of Guillemot Corp is -25.44

What is the cash to sales ratio of Guillemot Corp?

The cash to sales ratio of Guillemot Corp is 0.49

What is the registered address of Guillemot Corp?

The registered address for Guillemot Corp is 2 Rue du Chêne Héleuc, Carentoir, Brittany, 56910

What is the Guillemot Corp website address?

The website address for Guillemot Corp is www.guillemot.com

Which industry sector does Guillemot Corp operate in?

Guillemot Corp operates in the Technology Hardware, Storage & Peripherals sector

FormalMHRAconsultant

FormalMHRAconsultant 41秒前

when at the time that data was not available and approval was to be based on it.

Let's be careful about taking the "IPD wasn't available despite extensive efforts" line at face value because that's NWBO's own account, in NWBO's own slides. It isn't independent evidence; it's the self-

mdb1

Sad .. very sad ...

atonal17

atonal17 5分前

Yeah something is stinky here. I thought the holdup on anything significant was due to the CSE "dark period" where the company was unable to release any news that could hinder or circumvent the change of business application. The name change should just be a formality and not any kind of catalyst. T

flipper44

flipper44 6分前

I asked Google Gemini to put your original thread post in plain English. Here is a long winded but understandable translation.

Here is a breakdown of what Becky Willoughby’s post means in plain English, followed by an analysis of how it might connect to Northwest Biotherapeutics (NWB

MasterBlastr

MasterBlastr 7分前

I fell asleep, but things looking a little more perky now.

SHORENUFFSTUFF

SHORENUFFSTUFF 9分前

I went to the smoke shop only to discover it'd been replaced by an apparel store......
Clothes, but no cigar.

A man is driving with his wife at his side and his mother-in-law in the backseat.
The women don't leave him alone. His mother-in-law says, "You're driving too f

John Doe 2024

John Doe 2024 10分前

In the last 5 years anytime the price started to increase it was met by relentless dilution to stop it in its tracks then diluted back down. The Duffys need to get paid!!!!
Let's see what A.I has to say about it!!

How much have the Duffy brothers pocketed off the comoany Xerian

Red_Right_Hand

Red_Right_Hand 11分前

True, not exactly. She had years, and 'armies of consultants,' and perhaps they were all satisfied that their entity structure was sufficient to qualify to receive an MA at the time of filing (and perhaps it actually was), but a government bureaucrat said otherwise and so now they're sorting through

Hole shot King

Hole shot King 11分前

Google is a great tool for looking up people's names and see what comes up 🙈

Implanting

Implanting 12分前

I just watched this video and it's packed with information about what's happening with gold and the overall financial landscape. It has good insight as to what both China and the U.S. are attempting to do going forward.

Towards the end of the video the narrator gives four possible sc

Lightning_Rod

Lightning_Rod 13分前

SMR Prospects

The future for small modular reactors (SMRs) in the United States is probably much better than it looked two or three years ago, but it is unlikely to be a smooth or rapid rollout.

Assessment: SMRs are moving from the “research and promise” stage into the

RRP60

The burden is on our company to convince mhra and win over a favorable decision. mhra has every right to ask any question. Afterall, they are answerable to their people. Linda, probably the ball is in your court. Bring out your A game now. Iam waiting.

learningcurve2020

learningcurve2020 14分前

True, not exactly. But she had years and years to get that right assuming that’s an actual issue. Add to it she’s had a Specials program in the UK for a decade.

>> Could some of the delay be related to the need for NW to legally modify its entity structure so that there is a qualifyi

fredscott36

fredscott36 16分前

ANOTHER WEIRD AND WEIRDER WITH THIS POS......since we located our 350,000 shares of FCNCA.......through Broadridge and we believe further held in a Vanguard fund..........but get this......we asked A-I if Broadridge held stock as a fiduciary.........and got this answer................Yes, through it

Karma84

Karma84 16分前

Here’s the full write up and details. What an idiot. And look at all the criminal elements to it.

https://x.com/opinioncasino/status/2075924056033931353?s=46&t=GJF4mYq9oxQgaoD9fp1cvw

Red_Right_Hand

Red_Right_Hand 18分前

No that's not what this suggests and isn't at all what I said.

Krombacher

Krombacher 20分前

Why all this nervousness by presumed short sellers?

If there's a "big reveal" next week, then just sit tight and wait

More nervous clucking going on here than in a hen house!

learningcurve2020

learningcurve2020 20分前

So you think LP decided to slow down MHRA approval by folding Advent into NWBO when she did? LOL. But a good find.

i_like_bb_stock

i_like_bb_stock 22分前

i_like_bb_stock

i_like_bb_stock 22分前

I’ll take it gotta do some digging this weekend

oldstocks

oldstocks 23分前

Can you cite any court records, regulatory filings, press releases, or other evidence to support the suggestion that Dilan Gonzalez or Cade Carter are facing legal charges.

This is a serious allegation, and without supporting evidence it should be treated as an unsupported rumor.

i_like_bb_stock

i_like_bb_stock 23分前

Boing x 2

Boing x 2 23分前

It appears that we might be close to an end of selling and making a bottom.

Jul 10, 2026 3.8300 3.8700 3.7800 3.8500 3.8500 11,632,400
Jul 9, 2026 3.8600 3.9000 3.8000 3.8600 3.8600 15,737,700
Jul 8, 2026 3.8600 3.8800 3.7000 3.7800 3.7800 30,854,800

Gold

pdicamillo1

pdicamillo1 23分前

And I think we should discuss the risk of non-consensual DNA collection with these different oral fluid drug detection devices. This topic is way over my head so I did ask Gemini to explain it further:

And if anyone else has further insight please feel free to add some knowledge. Fe

RRP60

I will take back my earlier rant. Mhra and fda are the agencies working on the highest integrity out there. I should not blame them, just because my application is not yet processed in my favor. If there is a negative decision, i will respect it and ask the company to rectify it if possible and refi

State Street SPDR S&P 50...

First US Bancshares

Kwangdong Pharmaceutical

LB Pharmaceuticals

Invesco Trust Invesco Do...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。